Roman Butler Fullerton & CO Teva Pharmaceutical Industries LTD Transaction History

Roman Butler Fullerton & CO

  • $334 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2019

Jul 22, 2019
SELL
$8.12 - $15.72 $149,294 - $289,027
-18,386 Closed
0 $0
Q1 2019

Apr 24, 2019
SELL
$15.58 - $20.01 $11,669 - $14,987
-749 Reduced 3.91%
18,386 $288,000
Q4 2018

Feb 04, 2019
BUY
$14.59 - $23.84 $279,179 - $456,178
19,135 New
19,135 $348,000

Others Institutions Holding TEVA

# of Institutions
625
Shares Held
573M
Call Options Held
19.6M
Put Options Held
6.77M
View Full List

About TEVA PHARMACEUTICAL INDUSTRIES LTD

TEVA Quotes by TradingView
  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $25.3B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Roman Butler Fullerton & CO Portfolio

Follow Roman Butler Fullerton & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Roman Butler Fullerton & CO, based on Form 13F filings with the SEC.

News

Stay updated on Roman Butler Fullerton & CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email